Integra LifeSciences Holdings Corp sell JPMorgan Chase & Co.
Start price
24.05.23
/
50%
€36.80
Target price
24.05.24
€39.84
Performance (%)
-28.80%
Price
25.04.24
€26.20
Summary
This prediction is currently active. The price of Integra LifeSciences Holdings Corp has decreased since the start of the prediction. Compared to the start price this results in a performance of -28.80%. This prediction currently runs until 24.05.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Integra LifeSciences Holdings Corp | -9.459% | -9.459% |
| iShares Core DAX® | 1.051% | -1.833% |
| iShares Nasdaq 100 | -0.547% | -3.738% |
| iShares Nikkei 225® | -1.778% | -8.115% |
| iShares S&P 500 | 0.002% | -2.226% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Integra LifeSciences Holdings Corp diskutieren
Integra LifeSciences Holdings Co. (NASDAQ: IART) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $43.00 price target on the stock, down previously from $56.00.
Ratings data for IART provided by MarketBeat